BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25336430)

  • 1. Understanding the role of circulating chemokine (C-C motif) ligand 2 in patients with chronic ischemia threatening the lower extremities.
    Rull A; Hernandez-Aguilera A; Fibla M; Sepulveda J; Rodríguez-Gallego E; Riera-Borrull M; Sirvent JJ; Martín-Paredero V; Menendez JA; Camps J; Joven J
    Vasc Med; 2014 Dec; 19(6):442-51. PubMed ID: 25336430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of combined assessment of defense against oxidative stress and inflammation in the evaluation of peripheral arterial disease.
    Rull A; García R; Fernández-Sender L; Beltrán-Debón R; Aragonès G; Alegret JM; Alonso-Villaverde C; Mackness B; Mackness M; Camps J; Martin-Paredero V; Joven J
    Curr Mol Med; 2011 Aug; 11(6):453-64. PubMed ID: 21663591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chemokine (C-C motif) ligand 2 gene -2518 A/G polymorphism and pancreatitis risk: a meta-analysis.
    Fang F; Pan J; Xu L; Su G; Li G; Wang J
    Pancreatology; 2015; 15(1):53-8. PubMed ID: 25499426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Duffy blood group alloantigen system influences the measurement of monocyte chemoattractant protein-1 (MCP-1) in serum but not in plasma.
    Aragonès G; Ercilla A; Barreda M; Rull A; Beltrán-Debón R; Rodríguez-Gallego E; Alonso-Villaverde C; Camps J; Joven J
    Clin Lab; 2012; 58(1-2):185-8. PubMed ID: 22372364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.
    Thames AD; Briones MS; Magpantay LI; Martinez-Maza O; Singer EJ; Hinkin CH; Morgello S; Gelman BB; Moore DJ; Heizerling K; Levine AJ
    AIDS; 2015 Jul; 29(12):1483-91. PubMed ID: 26244388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CC-chemokine ligand-2 gene polymorphisms with leprosy reactions.
    Biswas SK; Mohanty KK; Singh V; Natrajan M; Arora M; Chakma JK; Tripathy SP
    Microbes Infect; 2024; 26(4):105298. PubMed ID: 38244764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.
    Attar R; Agachan B; Kuran SB; Cacina C; Sozen S; Yurdum LM; Attar E; Isbir T
    In Vivo; 2010; 24(2):243-8. PubMed ID: 20364004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis.
    Okumoto S; Taniguchi Y; Nakashima A; Masaki T; Ito T; Ogawa T; Takasugi N; Kohno N; Yorioka N
    Ther Apher Dial; 2009 Jun; 13(3):205-12. PubMed ID: 19527467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine (C-C motif) ligand 2 and coronary artery disease: Tissue expression of functional and atypical receptors.
    Hernández-Aguilera A; Fibla M; Cabré N; Luciano-Mateo F; Camps J; Fernández-Arroyo S; Martín-Paredero V; Menendez JA; Sirvent JJ; Joven J
    Cytokine; 2020 Feb; 126():154923. PubMed ID: 31739217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis.
    Wang L; Yang L; Gao L; Gao TW; Li W; Liu YF
    Int J Immunogenet; 2008 Feb; 35(1):45-9. PubMed ID: 18093183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.
    Gilbert J; Lekstrom-Himes J; Donaldson D; Lee Y; Hu M; Xu J; Wyant T; Davidson M;
    Am J Cardiol; 2011 Mar; 107(6):906-11. PubMed ID: 21247529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout.
    Grainger R; McLaughlin RJ; Harrison AA; Harper JL
    Rheumatology (Oxford); 2013 Jun; 52(6):1018-21. PubMed ID: 23204548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of paraoxonases and chemokines in arteries of patients with peripheral artery disease.
    Hernández-Aguilera A; Sepúlveda J; Rodríguez-Gallego E; Guirro M; García-Heredia A; Cabré N; Luciano-Mateo F; Fort-Gallifa I; Martín-Paredero V; Joven J; Camps J
    Int J Mol Sci; 2015 May; 16(5):11323-38. PubMed ID: 25993297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lower limbs' arterial calcification on the prevalence and severity of PAD in patients on hemodialysis.
    Ohtake T; Oka M; Ikee R; Mochida Y; Ishioka K; Moriya H; Hidaka S; Kobayashi S
    J Vasc Surg; 2011 Mar; 53(3):676-83. PubMed ID: 21211928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.
    Martinez-Aguilar E; Gomez-Rodriguez V; Orbe J; Rodriguez JA; Fernández-Alonso L; Roncal C; Páramo JA
    J Vasc Surg; 2015 Feb; 61(2):428-35. PubMed ID: 25441671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Duffy antigen receptor for chemokines (DARC) polymorphism that determines pro-fibrotic chemokine serum concentrations is not directly associated with severity of hepatitis C infection.
    Lettow I; Berres ML; Schmitz P; Müller T; Berg T; Neumann UP; Trautwein C; Wasmuth HE
    Hum Immunol; 2011 Mar; 72(3):273-7. PubMed ID: 21156192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of chemokine gene variants with end stage renal disease in North Indian population.
    Singh V; Jaiswal PK; Tiwari P; Kapoor R; Mittal RD
    Transpl Immunol; 2013 Jun; 28(4):189-92. PubMed ID: 23615182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine profiling reveals decreased serum levels of CCL2 in active ocular toxoplasmosis.
    Rey A; Molins B; Llorenç V; Pelegrín L; Mesquida M; Adán A
    Br J Ophthalmol; 2013 Oct; 97(10):1338-42. PubMed ID: 23878135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel activator of C-C chemokine, FROUNT, is expressed with C-C chemokine receptor 2 and its ligand in failing human heart.
    Satoh M; Akatsu T; Ishkawa Y; Minami Y; Nakamura M
    J Card Fail; 2007 Mar; 13(2):114-9. PubMed ID: 17395051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.